Skip to main content
. 2020 Sep 21;8(12):3105–3109. doi: 10.1002/ccr3.3348

Table 1.

Results of lymphocyte transformation test (LTT) and RUCAM scores

Antidepressant drug Class Drug concentration
0.1 µg/mL 1 µg/mL 10 µg/mL 50 µg/mL Result RUCAM
Stimulation index (SD) Score a 1st Score b 2nd
Amitriptyline TCA 0.5 (0.2) 0.5 (0.1) 0.3 (0.1) 0.3 (0.1) Negative Not involved Not involved
Aripiprazole SNRI 4.2 (0.7) 3.3 (0.4) 2.2 (0.4) 3.8 (0.6) Positive Not involved Not involved
Clomipramine TCA 0.8 (0.1) 2.3 (0.3) 0.5 (0.1) 0.2 (0.0) Positive Not involved +9
Escitalopram SSRI 0.3 (0.1) 0.7 (0.2) 0.7 (0.3) 0.3 (0.0) Negative Not involved Not involved
Lorazepam BZD +2 +2
Maprotiline TeCA 0.1 (0.0) 0.2 (0.1) 3.0 (0.8) 0.3 (0.1) Positive Not involved Not involved
Midazolam BZD +2 +2
Sertraline SSRI 3.9 (0.8) 1.4 (0.1) 0.8 (0.1) 0.2 (0.0) Positive Not involved Not involved
Trazodone SSRI 0.4 (0.2) 0.7 (0.1) 1.6 (0.6) 1.2 (0.2) Negative Not involved +6
Venlafaxine SNRI 0.8 (0.2) 2.0 (0.2) 4.0 (0.9) 2.7 0.1) Positive +10 Not involved
Vortioxetine SSRI 0.5 (0.0) 0.3 (0.0) 0.4 (0.1) 0.3 (0.1) Negative Not involved +10

Abbreviations: BZD, benzodiazepine; NDRI, norepinephrine‐dopamine reuptake inhibitor; RUCAM, Roussel Uclaf Causality Assessment Method; SD, Standard Deviation; SNRI, serotonin and norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; TCA, Tricyclic antidepressant; TeCA, Tetracyclic antidepressant.

a

Before hospitalization.

b

During hospitalization.